EPSTI1

Chr 13

epithelial stromal interaction 1

Also known as: BRESI1

The protein encoded by this gene has been shown to promote tumor invasion and metastasis in some invasive cancer cells when overexpressed. Expression of this gene has been shown to be upregulated by direct binding of the Kruppel like factor 8 protein to promoter sequences. The translated protein interacts with the amino terminal region of the valosin containing protein gene product, resulting in the nuclear translocation of the nuclear factor kappa B subunit 1 gene product, and activation of target genes. Overexpression of this gene has been observed in some breast cancers and in some individuals with systemic lupus erythematosus (SLE). [provided by RefSeq, Sep 2016]

ResearchGenerating clinical summary…
0
Active trials
24
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.72
LOEUF
Multiple*
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.72LOEUF
pLI 0.000
Z-score -1.38
OE 1.29 (0.98–1.72)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.43Z-score
OE missense 1.08 (0.97–1.21)
231 obs / 213.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.29 (0.98–1.72)
0≤0.351.4
Missense OE?1.08 (0.97–1.21)
0≤0.61.4
Synonymous OE?0.98
0≤1.21.6
LoF obs/exp: 33 / 25.5Missense obs/exp: 231 / 213.5Syn Z: 0.13

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

EPSTI1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →